Literature DB >> 1829749

IL-1ra ELISA: reduction and alkylation of synovial fluid eliminates interference by IgM rheumatoid factors.

M Malyak1, F G Joslin, E L Verderber, S P Eisenberg, W P Arend.   

Abstract

IL-1 and a specific receptor antagonist of IL-1, IL-1ra, may play important roles in the pathophysiology of rheumatoid arthritis and in other types of inflammatory synovitis. Measurement of IL-1ra in synovial fluids and in other body fluids may lead to a greater understanding of its possible activity as a modulator of the immune and inflammatory systems in vivo. Therefore, a modified sandwich ELISA was developed to measure IL-1ra protein concentration in synovial fluids. The antibodies used in this ELISA were polyclonal and derived from rabbits hyperimmunized with human recombinant IL-1ra. IgM rheumatoid factors within synovial fluid resulted in false elevation of determined IL-1ra by the sandwich ELISA through binding of the primary and secondary antibodies. Reduction and alkylation of synovial fluid samples before application to the ELISA plate eliminated the interference caused by greater than or equal to 2000 micrograms/ml IgM rheumatoid factor (latex agglutination titer of 1/5.120). This ELISA was specific for IL-1ra; there was no detection of IL-1 alpha, IL-1 beta, or lysozyme. The sensitivity of this ELISA was less than 200 pg/ml, making it a useful assay for the accurate measurement of synovial fluid IL-1ra protein concentration.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1829749     DOI: 10.1016/0022-1759(91)90381-o

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  10 in total

1.  Effect of inhaled glucocorticoids on IL-1 beta and IL-1 receptor antagonist (IL-1 ra) expression in asthmatic bronchial epithelium.

Authors:  A R Sousa; C J Trigg; S J Lane; R Hawksworth; J A Nakhosteen; R N Poston; T H Lee
Journal:  Thorax       Date:  1997-05       Impact factor: 9.139

2.  Hepatoprotective effects of baicalein against CCl₄-induced acute liver injury in mice.

Authors:  Hai-Li Huang; Ya-Jing Wang; Qing-Yu Zhang; Bin Liu; Fang-Yuan Wang; Jing-Jing Li; Run-Zhi Zhu
Journal:  World J Gastroenterol       Date:  2012-12-07       Impact factor: 5.742

3.  Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats.

Authors:  R B Kimble; J L Vannice; D C Bloedow; R C Thompson; W Hopfer; V T Kung; C Brownfield; R Pacifici
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

4.  Interleukin-1 receptor antagonist in normal and psoriatic epidermis.

Authors:  C Hammerberg; W P Arend; G J Fisher; L S Chan; A E Berger; J S Haskill; J J Voorhees; K D Cooper
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

5.  Early induction of IL-1 receptor antagonist (IL-1Ra) in infants and children undergoing surgery.

Authors:  E M O Nualláin; P Puri; D J Reen
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

6.  Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice.

Authors:  R Kitazawa; R B Kimble; J L Vannice; V T Kung; R Pacifici
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

7.  Peripheral blood neutrophil production of interleukin-1 receptor antagonist and interleukin-1 beta.

Authors:  M Malyak; M F Smith; A A Abel; W P Arend
Journal:  J Clin Immunol       Date:  1994-01       Impact factor: 8.317

8.  Activation of monocyte effector genes and STAT family transcription factors by inflammatory synovial fluid is independent of interferon gamma.

Authors:  T K Sengupta; A Chen; Z Zhong; J E Darnell; L B Ivashkiv
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

Review 9.  Interleukin 1 receptor antagonist. A new member of the interleukin 1 family.

Authors:  W P Arend
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

10.  False-positive detection of IgM anti-severe acute respiratory syndrome coronavirus 2 antibodies in patients with rheumatoid arthritis: Possible effects of IgM or IgG rheumatoid factors on immunochromatographic assay results.

Authors:  Shomi Oka; Takashi Higuchi; Hiroshi Furukawa; Kota Shimada; Atsushi Hashimoto; Toshihiro Matsui; Shigeto Tohma
Journal:  SAGE Open Med       Date:  2022-03-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.